1 Min Read
April 4 (Reuters) - Aphria Inc -
* Aphria launches US expansion strategy
* Aphria will invest $25 million into DFMMJ Investment Ltd
* Has agreed to licence Aphria Medical brand to Liberty, in exchange for perpetual 3% royalty on all sales of marijuana and related products
* Announces launch of its us expansion strategy through a strategic lead investment in an entity to be renamed Liberty Health Sciences Inc.
* As part of investment in Liberty, business combination, co to be entitled to appoint 2 nominees as board members to liberty's proposed 5-person board Source text for Eikon: Further company coverage: